EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Association of neonatal withdrawal syndrome with concurrent use of multiple neuropsychiatric medications in pregnant women

Miyako Nakagawa, Kosuke Doki, Mana Obata-Yasuoka, Hiromi Hamada, Daisuke Hitaka, Yayoi Miyazono, Hidetoshi Takada, Masato Homma

Early Human Development · 2025

DOI: 10.1016/j.earlhumdev.2025.106385 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Early Human Development, 2025. Verfasst von Miyako Nakagawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, Ibaraki 305-…. Hauptthemen laut MEDLINE: Neonatal Abstinence Syndrome, Pregnancy Complications. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Neonatal withdrawal syndrome is characterized by withdrawal symptoms in neonates because of the discontinuation of transplacental drug transfer after delivery. This study aimed to examine the risk factors for withdrawal symptoms to clarify the impact of the number of neuropsychiatric drugs administered during pregnancy. METHODS: This was a retrospective observational study including 344 neonates born to 341 mothers receiving neuropsychiatric drugs, including antipsychotics, antidepressants, antiepileptics, and anxiolytics/sedatives during pregnancy. The presence of withdrawal symptoms was assessed using the Isobe score, comprising 15 symptoms. Multivariable logistic regression analysis was performed to identify significant risk factors for the presence of withdrawal symptoms. RESULTS: Withdrawal symptoms developed in 178 (51.7 %) neonates. The frequency of neonates with withdrawal symptoms was higher in neonates born to mothers receiving ≥3 neuropsychiatric drugs compared to those born to mothers receiving 1-2 neuropsychiatric drugs (73.2 % vs. 45.0 %; P < 0.001). By multivariable logistic regression analysis, the presence of withdrawal symptoms was associated with the concurrent use of ≥3 neuropsychiatric drugs during pregnancy (adjusted odds ratio, 2.24; 95 % confidence interval, 1.09-4.62; P = 0.029) and the maternal use of antipsychotics (adjusted odds ratio, 1.77; 95 % confidence interval, 1.06-2.94; P = 0.028). CONCLUSIONS: The concurrent use of ≥3 neuropsychiatric drugs during pregnancy and the maternal use of antipsychotics were significant risk factors for the presence of withdrawal symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal Abstinence SyndromePregnancy ComplicationsHumansFemalePregnancyInfant, NewbornAdultRetrospective StudiesAntipsychotic AgentsRisk FactorsAntidepressive AgentsMaleAnticonvulsants

Stichwörter der Autor:innen

Neonatal withdrawal syndromePolypharmacyPoor neonatal adaptationPregnancyPsychotropic drugs

Substanzen

Antipsychotic AgentsAntidepressive AgentsAnticonvulsants

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, Ibaraki 305-8575, Japan; Department of Pharmacy, University of Tsukuba Hospital, 2…
  • Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, Ibaraki 305-8575, Japan.
  • Department of Pediatrics, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan.
  • Department of Child Health, Institute of Medicine, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, Ibaraki 305-8575, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nakagawa, M., Doki, K., Obata-Yasuoka, M., Hamada, H., Hitaka, D., Miyazono, Y., Takada, H., & Homma, M. (2025). Association of neonatal withdrawal syndrome with concurrent use of multiple neuropsychiatric medications in pregnant women. Early Human Development. https://doi.org/10.1016/j.earlhumdev.2025.106385

Vancouver

Nakagawa M, Doki K, Obata-Yasuoka M, Hamada H, Hitaka D, Miyazono Y, et al. Association of neonatal withdrawal syndrome with concurrent use of multiple neuropsychiatric medications in pregnant women. Early Human Development. 2025. doi:10.1016/j.earlhumdev.2025.106385

BibTeX
@article{Nakagawa2025,
  author = {Nakagawa, Miyako and Doki, Kosuke and Obata-Yasuoka, Mana and Hamada, Hiromi and Hitaka, Daisuke and Miyazono, Yayoi and Takada, Hidetoshi and Homma, Masato},
  title = {Association of neonatal withdrawal syndrome with concurrent use of multiple neuropsychiatric medications in pregnant women},
  journal = {Early Human Development},
  year = {2025},
  doi = {10.1016/j.earlhumdev.2025.106385}
}
Kostenlos starten →